Husband & Reznek's Imaging in Oncology

PART I: PRIMARY TUMOUR EVALUATION AND STAGING. Tumours of the oral cavity and pharynx. Paranasal sinus and nasal cavity neoplasms. Laryngeal tumours. Thyroid cancer. Mediastinal tumours. Lung cancer. Pleural tumours. Breast cancer. Oesophageal cancer. Gastric cancer. Primary tumours of the liver and biliary tract. Pancreatic malignancy. Renal cancer. Primary adrenal malignancy. Primary retroperitoneal tumours. Bladder cancer. Prostate cancer. Testicular cancer. Ovarian cancer. Cervical and uterine tumours. Colorectal cancer. Primary bone tumours. Soft tissue sarcomas. Neuroendocrine tumours. PART II: HAEMATOLOGICAL MALIGNANCY AND IMMUNE RELATED MALIGNANCY. Lymphoma. Multiple myeloma. PART III: METASTASES. Brain metastases. Lymph node metastases. Lung and pleural metastases. Bone metastases. Liver and spleen metastases. Adrenal metastases. Peritoneal metastases. PART IV: DISEASE RESPONSE AND TREATMENT. Assessment of response to treatment. Tumour-specific disease response criteria. Immunotherapy response. PART V: EFFECTS ON NORMAL TISSUE AND COMPLICATIONS OF TREATMENTS. Oncological effects on the central nervous system. Effects of treatment on the thorax. Effects of treatment on the abdomen and pelvis. Effects of treatment on bone and bone marrow. PART VI: FUNCTIONAL AND MOLECULAR IMAGING. PET-CT: Principles and clinical applications. Functional imaging and emerging techniques in MRI. Functional imaging and emerging techniques in CT. Non-FDG radionuclide imaging and targeted therapies.